Evaxion Announces Business Update and Second Quarter 2024 Financial Results
14 août 2024 07h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
Rumble Reports Second Quarter 2024 Results
12 août 2024 16h05 HE
|
Rumble, Inc.
~ Delivers Sequential Revenue Growth of 27% to $22.5 Million ~ ~ Introduces New KPI, Average Revenue Per User (ARPU), Up 19% Over First Quarter ~ LONGBOAT KEY, Fla., Aug. 12, 2024 (GLOBE...
Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14
12 août 2024 07h27 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Nova Leap Health Corp. Posts Q2 2024 Results that include a Continuation of Strong Operating Results, a Strong Balance Sheet and the Re-engagement of M&A
08 août 2024 17h00 HE
|
Nova Leap Health Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 08, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or...
SYLOGIST Reports Second Quarter 2024 Results
08 août 2024 06h00 HE
|
Sylogist Ltd.
SYLOGIST Reports Second Quarter 2024 Results
Sezzle Reports Second Quarter 2024 Results
07 août 2024 15h59 HE
|
Sezzle
Minneapolis, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, is pleased to update the market on key financial...
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11
07 août 2024 08h00 HE
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody® sonelokimab in...
Innospec Reports Second Quarter 2024 Financial Results
06 août 2024 16h45 HE
|
Innospec Inc.
Performance Chemicals operating income more than doubles on personal care growth Fuel Specialties operating income up double digits with margin expansion As expected, Oilfield Services results...
Navitas Semiconductor Announces Second Quarter 2024 Financial Results
05 août 2024 16h05 HE
|
Navitas Semiconductor Corporation
Q2 revenue and gross margin at higher end of guidanceFirst-half revenue up nearly 40% year-on-yearImportant AI data center advances in power systems roadmap to support Hopper, Blackwell, Blackwell...
AS Tallinna Vesi held an investor conference webinar to introduce the results of the second quarter of 2024
02 août 2024 04h02 HE
|
Tallinna Vesi
Today, on 2 August 2024, AS Tallinna Vesi held an investor conference webinar where Chairman of the Management Board, Chief Executive Officer Aleksandr Timofejev, and Member of the Management Board,...